A rare infection caused by Chryseomonas luteola.
Ghosh
S K
SK
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D002710:Chlorhexidine / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D048909:Diabetes Complications; D004338:Drug Combinations; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D016867:Immunocompromised Host; D008107:Liver Diseases / Q000150:complications; D009300:Nasal Septum / Q000473:pathology; D009355:Neomycin / Q000627:therapeutic use; D010195:Pancreatitis / Q000150:complications; D011014:Pneumonia / Q000150:complications; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D017192:Skin Diseases, Bacterial / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D014456:Ulcer / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology
D000890:Anti-Infective Agents; D000891:Anti-Infective Agents, Local; D004338:Drug Combinations; C070815:Naseptin; D002939:Ciprofloxacin; D009355:Neomycin; D002710:Chlorhexidine